TuesdayApr 27, 2021 2:30 pm

Former Texas Governor Implores Lawmakers to Pass Psychedelics Research Legislation

Former Republican Governor Rick Perry is backing legislation tabled by State Rep. Alex Dominguez, which pushes for psychedelic therapy treatments for veterans living with PTSD. The bill calls for a clinical study on psilocybin, which is the active ingredient found in magic mushrooms, to be conducted. In an interview last week, Perry stated that the measure was an optimistic piece of legislation that legislators have the opportunity to discuss during this session. Various studies have proposed that psilocybin could be an effective and safe treatment for various mental health conditions, such as depression. Perry noted that while he’s known to…

Continue Reading

MondayApr 26, 2021 2:30 pm

Research Finds Previous Use of Antidepressants May Reduce MDMA Effectiveness Against PTSD

A study conducted recently proposes that psychedelic-assisted therapy using MDMA to help treat PTSD is not as efficacious among individuals who have recently used psychiatric drugs commonly prescribed by doctors, known as selective serotonin re-uptake inhibitors. The research findings were reported in the “Psychopharmacology” journal. Allison Feduccia, director of education platform Psychedelic Support and author of the study, explained that antidepressants, in particular SSRIs and MDMA, bound themselves to the same receptors in an individual’s brain. She noted that if an individual used selective serotonin reuptake inhibitors and MDMA concurrently, the effects of the psychedelic would be decreased.  Feduccia added…

Continue Reading

FridayApr 23, 2021 2:00 pm

New Study Suggests That Psilocybin Could Boost Neuroplasticity

Researchers from the University of Copenhagen in Denmark suggest that psilocybin, which is the main active ingredient found in magic mushrooms, may give rise to speedy and lasting antidepressant effects because it increases neuroplasticity in the brain. The study, which was reported in the “International Journal of Molecular Sciences,” has discovered evidence that psilocybin grows the number of neural connections in the hippocampus and prefrontal cortex of pig brains. Psilocybin has been shown to possess long-lasting and profound effects on mood and personality. However, the mechanisms behind these effects are still not clear. For their study, the scientists from Copenhagen…

Continue Reading

ThursdayApr 22, 2021 2:00 pm

First-of-a-Kind Study Identifies Benefits of Group Psychedelic-Assisted Therapy Sessions

Psychedelics have become a popular topic of conversation, as well as of indulgence. While most of these substances remain outlawed in many countries across the globe, this has apparently not stopped people from accessing or using them. One of the reported common ways of consuming these drugs is in groups. Until recently, however, there hasn’t been any data to measure the possible value an individual derived from a group psychedelic experience. That has now changed. A new study that was published recently has found that using psychedelics within group settings (retreats or religious ceremonies, for example), could trigger increases in…

Continue Reading

WednesdayApr 21, 2021 1:45 pm

Microdosing on Psychedelic Drugs Linked to Broad Range of Effects

In recent years, microdosing has become popular as a wellness trend, both in the United States as well as overseas in countries such as Australia. Microdosing involves consuming a low dose of a psychedelic drug to reduce anxiety and stress or boost performance. While there have been some accounts by consumers who sing the praises of psychedelics, questions about how much of the reported benefits stem from the substances’ pharmacological effects rather than the partaker’s expectations and beliefs, and how microdosing works, still remain. To help answer some of these questions, we’ll look at a few studies on microdosing and…

Continue Reading

TuesdayApr 20, 2021 3:00 pm

Fireside Project Set to Launch Peer Support Line for Psychedelic Users

The Fireside Project is set to launch the first psychedelics peer support hotline in the world. Its creator, Joshua White, revealed that the concept behind the support line was to offer support to people who are experiencing an intense psychedelic trip or those who want to process an intense psychoactive experience they’ve gone through. White stated that the idea came to him last year, a few months into the coronavirus pandemic. He explained that the dark series of events that occurred during the summer, coupled with San Francisco’s infamous orange sky, led him to the realization that tied mental health…

Continue Reading

MondayApr 19, 2021 12:40 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces LOI Aimed at U.S. Expansion

Pure Extracts plans affiliate partnership to install cannabis and hemp extraction system in existing Michigan facility Company CEO notes excitement about launching into first US initiative with experienced and entrenched partners Agreement outlines planned renovation of existing 2,600-square-foot facility located in central Michigan Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and functional mushrooms, has inked a letter of intent (“LOI”) to form a joint venture that paves the way for the company’s entrance into the United States. Based on the LOI, PULL will partner with the affiliate of a publicly traded multi-state…

Continue Reading

MondayApr 19, 2021 11:31 am

Could Blockchain Tech Be a Boon for Psychedelics?

In the first few months of 2018, the Multidisciplinary Association for Psychedelic Studies was struggling to raise the finances it needed to conclude phase 3 of its clinical trials, which would allow the FDA to approve its MDMA-assisted therapy. Surprisingly, the funds were availed to the nonprofit organization through cryptocurrency. An anonymous individual, using the name Pine, created a philanthropic project that has made donations to 60 charities in the form of Bitcoin, known as the Pineapple Fund. The anonymous donor donated $5 million dollars’ worth of Bitcoin to MAPS, which enabled the organization to continue with its invaluable research…

Continue Reading

FridayApr 16, 2021 12:30 pm

Researchers to Study Effects of Nature-Themed Film on Psilocybin-Assisted Therapy

With psychedelics going mainstream, it should come as no surprise that researchers are planning to conduct a trial evaluating the treatment of alcohol use disorder using psilocybin, which is commonly known as a magic mushroom. Director of the Pacific Neuroscience Institute Daniel Kelly, who is also a neurosurgeon, will be carrying out the trial using a new approach, which will also employ the use of a nature-themed video. The filmmaker who created the video, Louie Schwartzberg, asserted that the film was not only historic but also truly groundbreaking work. Prior research has shown that video can enhance a psychedelic experience…

Continue Reading

FridayApr 16, 2021 12:15 pm

Largely Untapped Market for Hallucinogenic Draws Attention of Researchers at XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

XPhyto Therapeutics Corp., a life sciences technology accelerator, is looking for ways to turn promising psychedelics into therapeutic pharmaceutical drugs, and recently added mescaline to its study profile Mescaline is illegal under U.S. federal law, but some state-centric efforts to legalize or decriminalize the hallucinogenic have launched in a manner similar to the populace effort that produced a wave of cannabis product legalization Mescaline has historically defied predictable outcomes by researchers, but advocates cite it as a means of successfully treating some mental health and substance abuse disorders A number of psychedelics production stocks saw huge gains during the past…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000